Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Not applicable Interventional

Novel Endoluminal Clinical TreAtment of Reflux

ClinicalTrials.gov ID: NCT03090607

Public ClinicalTrials.gov record NCT03090607. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 18, 2026, 12:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-month Double-blind, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Efficacy of Endoluminal Aluvra™ for the Treatment of Gastroesophageal Reflux Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a prospective, multi-center, double-blind, crossover, randomized controlled trial designed to demonstrate the safety and efficacy of Aluvra for the treatment of GERD.

Study identification

NCT ID
NCT03090607
Recruitment status
Not listed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Impleo Medical Inc.
Industry
Enrollment
100 participants

Conditions and interventions

Conditions

Interventions

Device · Drug

Eligibility (public fields only)

Age range
22 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2017
Primary completion
Jun 30, 2021
Completion
Jun 30, 2022
Last update posted
Mar 11, 2020

2017 – 2022

United States locations

U.S. sites
10
U.S. states
9
U.S. cities
10
Facility City State ZIP Site status
Keck School of Medicine of USC Los Angeles California 90033
Digestive Health Center Palo Alto California 94304
SOFI - Center for Esophageal Wellness Englewood Colorado 80113
Mayo Clinic Florida Jacksonville Florida 32224
Esophageal Institute of Atlanta Atlanta Georgia 30309
Northwestern Memorial Hospital Chicago Illinois 60611
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Washington University in Saint Louis St Louis Missouri 63110
The Oregon Clinic, Gastrointestinal and Minimally Invasive Surgery Division Portland Oregon 97213
Aurora Medical Center Summit Milwaukee Wisconsin 53066

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03090607, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 11, 2020 · Synced Sep 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03090607 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →